To use all functions of this page, please activate cookies in your browser.
My watch list
my.chemeurope.com
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
17 Current news of Evotec
rss |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
Evotec and Dow AgroSciences announce collaboration on Cellular Target Profiling
11-Jul-2013
Evotec AG announced that Evotec and Dow AgroSciences (DOW) have entered into a research collaboration with the objective of leveraging Evotec's chemical proteomics services to support compounds in development at Dow AgroSciences. To this end, Evotec will perform chemical proteomics services ...
Evotec to realign Discovery Chemistry Operations
10-Jul-2013
Evotec AG announced that it will close its Chemistry Operations in Thane, India. All chemistry efforts will now be performed at its Abingdon (UK) facility, answering to an increasing requirement to operate closer to the principal R&D laboratories of our major customers. All project work in Thane ...
Evotec AG announces multi-year agreement with The United States Environmental Protection Agency (EPA)
07-May-2012
Evotec AG announced that Evotec has entered into a multi-year compound management agreement with the United States EPA. The contract covers a period of five years and has a total value of up to EUR7.7 million (approx. USD 10 million).Under the agreement Evotec, through its San Francisco ...
PerkinElmer Completes Acquisition of Euroscreen Products SA And Evotec Technologies
15-Jan-2007
PerkinElmer, Inc. reported that it has successfully completed two previously announced acquisitions that will extend its portfolio of advanced tools for cellular analysis and High Content Screening (HCS). In the fourth quarter of 2006, the Company announced its intent to acquire Euroscreen ...
PerkinElmer to Acquire Evotec Technologies
04-Dec-2006
PerkinElmer, Inc. announced that it has signed a definitive agreement with Evotec AG to acquire its majority owned subsidiary, Evotec Technologies GmbH, in a cash transaction valued at approximately EUR 23 million. The transaction is subject to regulatory approvals and other customary closing ...
Procter & Gamble Selects Evotec as Provider of Pharmaceutical Discovery and Chemical Development Services
25-Jul-2005
Evotec AG and Procter & Gamble Pharmaceuticals, Inc. (P&GP), a subsidiary of The Procter & Gamble Company announced that they have entered into agreements whereby Evotec will provide pharmaceutical discovery and chemical development services to P&GP. Under the terms of the agreements, P&GP will ...
Biogen Idec Selects Evotec OAI as a Service Provider for Process Research & Development
19-Jul-2004
Evotec OAI AG a leading partner for integrated, high-value-added drug discovery and development solutions, today announced that Biogen Idec has selected Evotec OAI as one of its service providers for chemical process research and development and cGMP manufacturing. The companies have expanded ...
Evotec OAI and Roche enter into Strategic Global Discovery Chemistry Agreement
12-May-2004
Evotec OAI and Roche have a long-standing relationship that includes three chemistry alliances since 2001 when Evotec OAI began supporting four Roche sites in the design and synthesis of high quality chemical compounds. These compounds were added to the Roche compound library collection and used ...
Evotec OAI and Rib-X Pharmaceuticals Enter Into Medicinal Chemistry Collaboration
16-Jan-2004
Evotec OAI AG and Rib-X Pharmaceuticals, Inc., announced the formation of a medicinal chemistry partnership. Scientists from Rib-X and Evotec OAI will collaborate on several research programmes. Evotec OAI will be utilising its state-of-the-art integrated medicinal chemistry and parallel ...
Evotec OAI Signs Medicinal Chemistry Agreement with Axxima Pharmaceuticals
25-Jun-2003
Evotec OAI, a partner for integrated high-value-added drug discovery services to the pharmaceutical and biotechnology industries, and Axxima Pharmaceuticals AG, a drug discovery and development company leading the field of pathogen-host signal transduction, today announced that they have entered ...
